LOTEMAX SM Is Formulated with SubMicron Technology for Efficient Penetration To Key Ocular Tissues 1 BRIDGEWATER, N.J., Feb. 25, 2019 /CNW/ -- Bausch + Lomb, a leading global eye health company and ...

Bausch + Lomb has announced it has received FDA approval of the company’s new drug application for LOTEMAX 0.5 percent gel drop formulation, according to a news release. The LOTEMAX (loteprednol ...